XBP1 PEPTIDE, CD138 PEPTIDE, AND CS1 PEPTIDE

Japanese Patent JP2015063559

A

PROBLEM TO BE SOLVED: To provide a XBP1 peptide, a CD138 peptide, and a CS1 peptide.SOLUTION: The disclosure features, inter alia, immunogenic XBP1-, CD138-, and CS1-derived peptides (and pharmaceutical compositions thereof). The peptides can be used in a variety of methods such as methods for inducing an immune response, methods for producing an antibody, and methods for treating a cancer (e.g., a plasma cell disorder such as multiple myeloma or Waldenstrom's macroglobulinemia). The peptides can also be included in MHC molecule multimer compositions and used in, e.g., methods for detecting a T cell in a population of cells.

WO/1995/008630	SURFACE LOOP STRUCTURAL ANALOGUES OF FIBROBLAST GROWTH FACTORS
WO/2003/008586	ENGINEERING ONCOLYTIC VIRUSES
JP2004524824	Genes associated with mechanical stress, expression products from them, and their uses

NIKHIL C MUNSHI
BAE JOOEUN
ANDERSON KENNETH C

JP2014262194A

April 09, 2015

December 25, 2014

Click for automatic bibliography generation  

DANA FARBER CANCER INST INC

A61K38/00; A61K39/00; A61K39/39; A61K45/00; A61P35/00; A61P43/00

JP2007503465A	2007-02-22
JP2007530675A	2007-11-01
JP2007503465A	2007-02-22
JP2007530675A	2007-11-01

WO2008019378A1	2008-02-14
WO2008019376A2	2008-02-14
US20030113332A1	2003-06-19
WO2008019378A1	2008-02-14
WO2008019376A2	2008-02-14
US20030113332A1	2003-06-19

JPN6010014502; Ｊ．　Ｉｍｍｕｎｏｌ． Ｖｏｌ．１６７，　Ｎｏ．１０, 2001, ｐ．５５１７-５５２１
JPN6015044214; Ｃｌｉｎｉｃａｌ　ｃａｎｃｅｒ　ｒｅｓｅａｒｃｈ Ｖｏｌ．９，　Ｎｏ．５, 2003, ｐ．１８５０-１８５７
JPN6015044214; Ｃｌｉｎｉｃａｌ　ｃａｎｃｅｒ　ｒｅｓｅａｒｃｈ Ｖｏｌ．９，　Ｎｏ．５, 2003, ｐ．１８５０-１８５７
JPN6010014502; Ｊ．　Ｉｍｍｕｎｏｌ． Ｖｏｌ．１６７，　Ｎｏ．１０, 2001, ｐ．５５１７-５５２１

Hidesaku Yamamoto
Natsuki Morishita

Previous Patent: VACCINE COMPOSITIONS COMPRISING MUTATED FACTOR H BINDING PROTEIN

Next Patent: METHOD FOR PRODUCING AROMATIC HYDROCARBON